Home » Newsletters » BioWorld Asia

BioWorld Asia

March 10, 1999

View Archived Issues

Amrad Sells Baxter Rights To Heart Protein For $22M

NeuroSearch, P&U Ending Deal On Anxiety Treatment

On-The-Spot Tests Could Let Physicians Identify Genotype, Determine Strongest Treatment

Oxford Ends Year Strong; Deals Fuel Cash Position

Inpharmatica Raises #3M In Second Financing Round

RPR Joins Genetics Institute Roster Of Database Buyers

Axis, Roche Join Forces To Test Animal Vaccines

Chiroscience Regains Rights To Lead Anesthetic Product

Actinova In Three-Way Pact For Streptococcus Vaccine

Oxford BioMedica Raising #3.6M For Cancer Study

SR Pharma, Corixa Enter Second Licensing Deal

Stocks Follow Biota Slide After Flu Drugs Refusal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...